• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

八十岁以上患者接受胃食管腺癌根治性切除术的围手术期结局和生存情况。

Perioperative outcomes and survival of octogenarians undergoing curative resection for esophagogastric adenocarcinoma.

机构信息

Case Western Reserve University School of Medicine, Cleveland, Ohio.

Department of Surgery, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.

出版信息

J Surg Oncol. 2020 May;121(6):1015-1021. doi: 10.1002/jso.25866. Epub 2020 Feb 23.

DOI:10.1002/jso.25866
PMID:32090338
Abstract

BACKGROUND AND OBJECTIVES

Current data are conflicting as to whether the outcomes of octogenarians undergoing resection for esophagogastric adenocarcinoma are comparable to younger patients. This study aims to compare perioperative outcomes and survival of patients ≥80 years old with younger patients undergoing curative resection for esophagogastric adenocarcinoma.

METHODS

Retrospective data were collected on 190 patients who underwent resection with curative intent for adenocarcinomas found in the stomach and esophagogastric junction from 2004 to 2015 at a single institution.

RESULTS

Of the 190 patients, 34 (18%) were ≥80 years old. Octogenarians were more likely to have chronic kidney disease (CKD) and were less likely to have received neoadjuvant chemotherapy. Pathologic features were similar between groups. Octogenarians' tumors were more likely to be located in the gastric body as compared to the esophagogastric junction in younger patients. Although the length of stay was comparable, octogenarians were significantly less likely to be discharged home (P < .01). Both groups had a single death during the index admission. Incidence and severity of 90 days postoperative complications were not significantly different between groups. There was no difference in 30-day, 90-day, 1-year, or median survival.

CONCLUSIONS

Perioperative outcomes and survival of octogenarians undergoing curative resection for esophagogastric cancer are comparable to younger patients at our institution.

摘要

背景与目的

目前对于 80 岁以上患者接受胃食管腺癌切除术的结果是否与年轻患者相当仍存在争议。本研究旨在比较 80 岁以上患者与接受根治性切除术的年轻患者的围手术期结局和生存情况。

方法

回顾性收集了 2004 年至 2015 年在一家医疗机构接受胃和食管胃交界腺癌根治性切除术的 190 例患者的数据。

结果

在 190 例患者中,有 34 例(18%)年龄≥80 岁。80 岁以上患者更有可能患有慢性肾脏病(CKD),且不太可能接受新辅助化疗。两组的病理特征相似。与年轻患者相比,80 岁以上患者的肿瘤更可能位于胃体而不是食管胃交界处。虽然住院时间相似,但 80 岁以上患者出院回家的可能性明显较小(P<.01)。两组在索引住院期间均有 1 例死亡。两组术后 90 天并发症的发生率和严重程度无显著差异。两组在 30 天、90 天、1 年或中位生存时间上均无差异。

结论

在我们的机构中,接受胃食管癌症根治性切除术的 80 岁以上患者的围手术期结局和生存情况与年轻患者相当。

相似文献

1
Perioperative outcomes and survival of octogenarians undergoing curative resection for esophagogastric adenocarcinoma.八十岁以上患者接受胃食管腺癌根治性切除术的围手术期结局和生存情况。
J Surg Oncol. 2020 May;121(6):1015-1021. doi: 10.1002/jso.25866. Epub 2020 Feb 23.
2
[Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].[机器人手术与腹腔镜辅助手术对食管胃交界部Siewert II型腺癌患者淋巴结清扫及短期预后的影响]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):156-163.
3
[Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].[经胸与经腹入路治疗食管胃交界部Siewert II型腺癌的生存比较:胸外科与胃肠外科联合数据分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Feb 25;22(2):132-142.
4
Perioperative Chemotherapy in Elderly Patients with Locally Advanced Adenocarcinoma of the Stomach and the Esophagogastric Junction: A Retrospective Cohort Analysis of Toxicity and Efficacy at the National Center for Tumor Diseases, Heidelberg.老年局部晚期胃癌和食管胃交界腺癌患者的围手术期化疗:海德堡国家肿瘤疾病中心毒性和疗效的回顾性队列分析
Oncology. 2017;92(5):291-298. doi: 10.1159/000458531. Epub 2017 Mar 2.
5
[Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].[食管胃交界腺癌:预后因素及初次手术结果]
Chirurg. 2004 Nov;75(11):1088-97. doi: 10.1007/s00104-004-0840-x.
6
Histopathologic response in patients with curative resection with D2 dissection following neoadjuvant treatment for locally advanced gastric and esophagogastric junction adenocarcinoma.新辅助治疗后接受D2根治性切除的局部晚期胃癌和食管胃交界腺癌患者的组织病理学反应。
Eur J Surg Oncol. 2024 Jul;50(7):108428. doi: 10.1016/j.ejso.2024.108428. Epub 2024 May 20.
7
Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.食管胃交界部癌患者的预后与组织学及手术策略的关系。
Hepatogastroenterology. 2003 Nov-Dec;50(54):1948-52.
8
Influence of Different Neoadjuvant Chemotherapy Regimens on Response, Prognosis, and Complication Rate in Patients with Esophagogastric Adenocarcinoma.不同新辅助化疗方案对食管胃腺癌患者反应、预后及并发症发生率的影响
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S905-14. doi: 10.1245/s10434-015-4617-x. Epub 2015 May 22.
9
[Optimal surgical approach for esophagogastric junction carcinoma].[食管胃交界部癌的最佳手术方式]
Nihon Geka Gakkai Zasshi. 2015 Jan;116(1):40-4.
10
Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type II adenocarcinoma of the esophagogastric junction.腹腔镜与开腹经食管裂孔入路手术治疗食管胃交界部 Siewert Ⅱ型腺癌的短期疗效比较。
Surg Endosc. 2018 Jan;32(1):383-390. doi: 10.1007/s00464-017-5687-6. Epub 2017 Jun 27.

引用本文的文献

1
Surgical outcomes and survival of patients over 80 years old who underwent curative resection for gastric cancer.80岁以上接受胃癌根治性切除术患者的手术结果及生存情况。
Ann Surg Treat Res. 2023 Dec;105(6):376-384. doi: 10.4174/astr.2023.105.6.376. Epub 2023 Nov 29.
2
Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis.老年患者的食管癌:当前治疗选择与结果;系统评价与汇总分析
Cancers (Basel). 2021 Apr 27;13(9):2104. doi: 10.3390/cancers13092104.